Back to AG Adage Capital Partners GP, L.L.C.

CRVOCRVO

Showing 2 of 6 quarters

Position history for AGAdage Capital Partners GP, L.L.C.'s holdings in CervoMed Inc.

No. Adage Capital Partners GP exited its CRVO (CervoMed) position in Q4 2024. Its Q3 2024 13F listed 28,600 shares worth $417,560. Adage Capital Partners GP first reported CRVO in Q3 2023 and held it in 5 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$417,560

Total Shares Change

-28,600

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q4
Latest
Exited
0
-100.0%
$00.0%$2.34
0
2024-Q3
Decreased
28,600
-28.6%
$417,5600.0%$14.60
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used